Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Antimicrobial Chemotherapy|April 15, 2022
Removal of doravirine by haemodialysis in people living with HIV with end-stage renal diseaseJosé Moltó, Fredzzia Graterol, Adrian Curran, et al.
Journal of the International AIDS Society|November 15, 2014
DRV concentrations and viral load in CSF in patients on DRV/r 600/100 or 800/100mg once daily plus two NRTISilvana Di Yacovo, Jose Molto, Elena Ferrer, et al.
HIV Medicine|July 5, 2026
Mpox clinical outcomes among people living with HIV and PrEP users: Findings from the MASH-1 multicentre cohort studyNicolo Girometti, Andrew Hill, Bryony Simmons, et al.
Journal of the International AIDS Society|November 14, 2014
Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTCJosé Ramón Santos, María Saumoy, Adrian Curran, et al.
AIDS (London, England)|March 20, 2023
HIV medical care interruption among people living with HIV in Spain, 2004-2020Rebeca Izquierdo, Marta Rava, Estela Moreno-García, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2015
Darunavir and ritonavir total and unbound plasmatic concentrations in HIV-HCV-coinfected patients with hepatic cirrhosis compared to those in HIV-monoinfected patientsAdrian Curran, Ramon Martí, Rosa María López, et al.
International Journal of Rheumatic Diseases|January 10, 2018
Opportunistic infections in patients with idiopathic inflammatory myopathiesAda Redondo-Benito, Adrian Curran, Ana Villar-Gomez, et al.
Sexually Transmitted Infections|August 6, 2020
Screening for asymptomatic STIs in HIV-infected men who have sex with menRein Willekens, Irene Sánchez, Lucía Miguel, et al.
Journal of Virus Eradication|July 28, 2018
Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global healthChristina Psomas, Sabine Kinloch, Caroline Sabin, et al.
The Journal of Antimicrobial Chemotherapy|January 14, 2014
Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study GroupAdrian Curran, Polyana Monteiro, Pere Domingo, et al.
Pageof 8